A detailed history of Hodges Capital Management Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hodges Capital Management Inc. holds 75,324 shares of MRK stock, worth $7.39 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
75,324
Previous 61,517 22.44%
Holding current value
$7.39 Million
Previous $7.62 Million 12.32%
% of portfolio
0.57%
Previous 0.53%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$111.15 - $128.97 $1.53 Million - $1.78 Million
13,807 Added 22.44%
75,324 $8.55 Million
Q2 2024

Aug 02, 2024

SELL
$123.8 - $132.96 $601,668 - $646,185
-4,860 Reduced 7.32%
61,517 $7.62 Million
Q1 2024

Apr 16, 2024

SELL
$113.24 - $131.95 $259,432 - $302,297
-2,291 Reduced 3.34%
66,377 $8.76 Million
Q4 2023

Feb 13, 2024

BUY
$100.18 - $109.02 $2.75 Million - $2.99 Million
27,453 Added 66.61%
68,668 $7.49 Million
Q3 2023

Nov 14, 2023

SELL
$102.95 - $114.33 $853,764 - $948,138
-8,293 Reduced 16.75%
41,215 $4.24 Million
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $1.19 Million - $1.3 Million
10,956 Added 28.42%
49,508 $6.95 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $498,950 - $556,726
-4,847 Reduced 11.17%
38,552 $4.73 Million
Q4 2022

Feb 03, 2023

BUY
$87.44 - $112.11 $1.52 Million - $1.95 Million
17,360 Added 66.67%
43,399 $4.82 Million
Q3 2022

Oct 21, 2022

SELL
$84.53 - $94.96 $1.27 Million - $1.43 Million
-15,070 Reduced 36.66%
26,039 $2.24 Million
Q2 2022

Jul 28, 2022

BUY
$83.49 - $94.64 $1.63 Million - $1.85 Million
19,504 Added 90.28%
41,109 $3.75 Million
Q1 2022

May 12, 2022

SELL
$73.51 - $82.4 $64,688 - $72,512
-880 Reduced 3.91%
21,605 $1.77 Million
Q4 2021

Feb 07, 2022

SELL
$72.28 - $90.54 $23,418 - $29,334
-324 Reduced 1.42%
22,485 $1.72 Million
Q3 2021

Oct 06, 2021

SELL
$71.68 - $78.83 $444,200 - $488,509
-6,197 Reduced 21.36%
22,809 $1.71 Million
Q2 2021

Jul 06, 2021

SELL
$70.31 - $77.77 $499,341 - $552,322
-7,102 Reduced 19.67%
29,006 $2.26 Million
Q1 2021

Apr 07, 2021

SELL
$68.86 - $81.11 $1 Million - $1.18 Million
-14,546 Reduced 28.72%
36,108 $2.78 Million
Q4 2020

Feb 01, 2021

SELL
$71.77 - $79.65 $311,912 - $346,158
-4,346 Reduced 7.9%
50,654 $4.14 Million
Q3 2020

Oct 15, 2020

BUY
$73.18 - $82.95 $187,853 - $212,932
2,567 Added 4.9%
55,000 $4.56 Million
Q2 2020

Jul 22, 2020

SELL
$70.42 - $80.13 $739,832 - $841,845
-10,506 Reduced 16.69%
52,433 $4.06 Million
Q1 2020

May 04, 2020

SELL
$63.36 - $87.82 $809,043 - $1.12 Million
-12,769 Reduced 16.87%
62,939 $4.84 Million
Q4 2019

Feb 04, 2020

BUY
$77.58 - $87.54 $45,306 - $51,123
584 Added 0.78%
75,708 $6.89 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $447,502 - $487,794
5,882 Added 8.49%
75,124 $6.32 Million
Q2 2019

Aug 22, 2019

SELL
$69.84 - $81.59 $4.08 Million - $4.77 Million
-58,453 Closed
0 $0
Q1 2019

Apr 15, 2019

BUY
$69.58 - $79.36 $3.02 Million - $3.44 Million
43,402 Added 288.37%
58,453 $4.86 Million
Q4 2018

Feb 08, 2019

SELL
$65.24 - $75.71 $34,120 - $39,596
-523 Reduced 3.36%
15,051 $1.15 Million
Q3 2018

Oct 29, 2018

SELL
$57.69 - $67.84 $19,095 - $22,455
-331 Reduced 2.08%
15,574 $1.11 Million
Q2 2018

Jul 26, 2018

SELL
$50.83 - $59.72 $12,910 - $15,168
-254 Reduced 1.57%
15,905 $965,000
Q1 2018

May 03, 2018

SELL
$50.96 - $59.23 $101,665 - $118,163
-1,995 Reduced 10.99%
16,159 $880,000
Q4 2017

Feb 06, 2018

SELL
$51.62 - $61.64 $463,031 - $552,910
-8,970 Reduced 33.07%
18,154 $1.02 Million
Q3 2017

Nov 02, 2017

BUY
$58.67 - $63.13 $1.59 Million - $1.71 Million
27,124
27,124 $1.74 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Hodges Capital Management Inc. Portfolio

Follow Hodges Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hodges Capital Management Inc. with notifications on news.